ChemInform Abstract: Conversion of 4-Cyanomethyl-pyrazole-3-carboxamides into CB1 Antagonists with Lowered Propensity to Pass the Blood—Brain-Barrier.
Jean-Marie Receveur, Anthony Murray, Jean-Michel Linget, Pia K. Noerregaard, Martin Cooper, Emelie Bjurling, Peter Aadal Nielsen, Thomas HoegbergVolume:
41
Year:
2010
Pages:
1
DOI:
10.1002/chin.201023117
File:
PDF, 19 KB
2010